Needlestick Injuries in the United States: Epidemiologic, Economic, and Quality of Life Issues

Workplace Health and Safety

Volumn 53, Issue 3, 2005, Pages 117-133

  Lee, Jennifer M ^a   Botteman, Marc F ^a   Xanthakos, Nicholas ^a   Nicklasson, Lars ^b  

^a ABT ASSOCIATES   (United States)

^b NOVO NORDISK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WASTE DISPOSAL;

BIOENGINEERING; COMPLICATION; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEVICES; DISEASE TRANSMISSION; ECONOMICS; EPIDEMIOLOGY; EQUIPMENT DESIGN; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HOSPITAL PERSONNEL; HUMAN; INCIDENCE; NEEDLESTICK INJURIES; OCCUPATIONAL ACCIDENT; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TRANSMISSION; UNITED STATES; WASTE DISPOSAL;

ACCIDENTS, OCCUPATIONAL; ATTITUDE OF HEALTH PERSONNEL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EPIDEMIOLOGIC RESEARCH DESIGN; EQUIPMENT DESIGN; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMAN ENGINEERING; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; MEDICAL WASTE DISPOSAL; NEEDLESTICK INJURIES; PERSONNEL, HOSPITAL; POPULATION SURVEILLANCE; QUALITY OF LIFE; RISK FACTORS; UNITED STATES;

EID: 18244378778     PISSN: 21650799     EISSN: 21650969     Source Type: Journal    
DOI: 10.1177/216507990505300311     Document Type: Review

References (92)

1. Aiken L.H., Sloane D.M., & Klocinski J.L. (1997). Hospital nurses' occupational exposure to blood: Prospective, retrospective, and institutional reports. American Journal of Public Health, 87, 103–107.
2. Alvarado-Ramy F., Beltrami E.M., Short L.J., Srivastava P.U., Henry K., Mendelson M., Gerberding J.L., Delclos G.L., Campbell S., Solomon R., Fahmer R., Culver D.H., Bell D., Cardo D.M., & Chamberland M.E. (2003). A comprehensive approach to percutaneous injury prevention during phlebotomy: Results of a multicenter study, 1993-1995. Infection Control and Hospital Epidemiology, 24, 97–104.
3. Anglin D., Kyriacou D.N., & Hutson H.R. (1994). Residents' perspectives on violence and personal safety in the emergency department. Annals of Emergency Medicine, 23, 1082–1084.
4. Anonymous. (1984). Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet, 2, 1376–1377.
5. Anonymous. (2003). Ranking regulatory investments in public health. FY 2003 Budget—Analytical Perspectives Section 24, and the Technical Appendix. Retrieved February 4, 2005, from www.white-house.gov/omb/inforeg/spec24.pdf
6. Bamberg R., Rivers C., & Moore C. (2003). Use of needle safety devices by clinical laboratories in North Carolina hospitals. Clinical Leadership and Management Review, 17(1), 21–25.
7. Beekmann S.E., Vlahov D., Koziol D.E., McShalley E.D., Schmitt J.M., & Henderson D.K. (1994). Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. Clinical Infectious Diseases, 18, 562–569.
8. Benninger M.S., Gupta N., & Gilmore K. (1991). Intraoperative infectious disease exposure to otolaryngology operating room personnel. Laryngoscope, 101, 1276–1279.
9. Blythe v. Radiometer America, Inc., Community Medical Center, 866 P.2d 218 (Mont. 1993).
10. Bouton R.A., Gallagher P.E., & Garlinghouse P.A. (1994). In Fischer J., & Corcoran K., Measures for clinical practice: A sourcebook (2nd ed., Vol. 2, pp. 211–213). New York: Free Press.
11. Buergler J.M., Kim R., Thisted R.A., Cohn S.J., Lichtor J.L., & Roizen M.F. (1992). Risk of human immunodeficiency virus in surgeons, anesthesiologists, and medical students. Anesthia & Analgesia, 75, 118–124.
12. California Occupational Safety and Health Administration. (1998). Bloodborne pathogens. California Code of Regulations. Title 8. Section 5193.
13. Cardo D.M., Culver D.H., Ciesielski C.A., Srivastava P.U., Marcus R., Abiteboul D., Heptonstall J., Ippolito G., Lot F., McKibben P.S., & Bell D.M. (1997). A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. New England Journal of Medicine, 20(337), 1485–1490.
14. Centers for Disease Control and Prevention (CDC). (2003). Surveillance of healthcare personnel with HIV/AIDS, as of December 2002. Retrieved October 28, 2003, from www.cdc.gov/ncidod/hip/BLOOD/hivpersonnel.htm
15. Cheng F.K., Ford W.L., Cheng S.Y., Weber M.D., & Kerndt P.R. (1995). Occupational risk of acquiring HIV infection through needlestick injuries. Clinical Performance and Quality Health Care, 3, 147–150.
16. Dale J.C., Pruett S.K., & Maker M.D. (1998). Accidental needlesticks in the phlebotomy service of the Department of Laboratory Medicine and Pathology at Mayo Clinic Rochester. Mayo Clinic Proceeding, 73, 611–615.
17. Do A.N., Ciesielski C.A., Metier R.P., Hammett T.A., Li J., & Fleming P.L. (2003). Occupationally acquired human immunodeficiency virus (HIV) infection: National case surveillance data during 20 years of the HIV epidemic in the United States. Infection Control and Hospital Epidemiology, 24, 86–96.
18. English J.F. (1992). Reported hospital needlestick injuries in relation to knowledge/skill, design, and management problems. Infection Control and Hospital Epidemiology, 13, 259–264.
19. Fisman D.N., Mittleman M.A., Sorock G.S., & Harris A.D. (2002). Willingness to pay to avoid sharps-related injuries: A study in injured health care workers. American Journal of Infection Control, 30, 283–287.
20. Fraser V.J. (1998). Infection control special report: After the needlestick. Materials Management in Health Care, 7(8), 30, 32, 34.
21. Freedberg K.A., Losina E., Weinstein M.C., Paltiel A.D., Cohen C.J., Seage G.R., Craven D.E., Zhang H., Kimmel A.D., & Goldie S.J. (2001). The cost effectiveness of combination antiretroviral therapy for HIV disease. New England Journal of Medicine, 344, 824–831.
22. Friedland L.R., Kulick R.M., Biro F.M., & Patterson A. (1996). Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis. Annals of Emergency Medicine, 27, 299–304.
23. Gable C.B., Tierce J.C., Simison D., Ward D., & Motte K. (1996). Costs of HIV positive/AIDS at CD4+ counts disease stages based on treatment protocols. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 413–420.
24. Gartner K. (1993). Impact of a needleless intravenous system in a university hospital. Journal of Healthcare Material Management, 11(8), 44–49.
25. Gerberding J.L. (1994). Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study. The Journal of Infectious Diseases, 170, 1410–1417.
26. Gerberding J.L., Littell C., Tarkington A., Brown A., & Schecter W.P. (1990). Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital. New England Journal of Medicine, 322, 1788–1793.
27. Gershon R.R., Flanagan P.A., Karkashian C., Grimes M., Wilburn S., Frerotte J., Guidera J., & Pugliese G. (2000). Health care workers' experience with postexposure management of bloodborne pathogen exposures: A pilot study. American Journal of Infection Control, 25, 421–428.
28. Gillen M., McNary J., Lewis J., Davis M., Boyd A., Schuller M., Curran C., Young C.A., & Cone J. (2003). Sharps-related injuries in California healthcare facilities: Pilot study results from the Sharps Injury Surveillance Registry. Infection Control and Hospital Epidemiology, 24, 113–121.
29. Grimes B.G. (1997). An overview of litigation concerning needlestick injuries in defective design and negligent use of equipment cases. Journal of Intravenous Nursing, 20 (Suppl. 6), S40–S44.
30. Haiduven D.J., DeMaio T.M., & Stevens D.A. (1992). A five-year study of needlestick injuries: Significant reduction associated with communication, education, and convenient placement of sharps containers. Infection Control and Hospital Epidemiology, 13, 265–271.
31. Hansen M.E., Miller G.L. III, Redman H.C., & McIntire D.D. (1993). Needle-stick injuries and blood contacts during invasive radiologic procedures: Frequency and risk factors. AJR American Journal of Roentgenology, 160, 1119–1122.
32. Hatcher I.B. (2002). Reducing sharps injuries among health care workers: A sharps container quality improvement project. The Joint Commission Journal on Quality Improvement, 28, 410–414.
33. Heald A.E., & Ransohoff D.F. (1990). Needlestick injuries among resident physicians. Journal of General Internal Medicine, 5, 389–393.
34. Hellinger F.J. (1991). Forecasting the medical care costs of the HIV epidemic: 1991-1994. Inquiry, 28, 213–225.
35. Hellinger F.J. (1992). Forecasts of the costs of medical care for persons with HIV: 1992-1995. Inquiry, 29, 356–365.
36. Hellinger F.J. (1993). The lifetime cost of treating a person with HIV. Journal of the American Medical Association, 270, 474–478.
37. Henderson D.K., Fahey B.J., Willy M., Schmitt J.M., Carey K., Koziol D.E., Lane H.C., Fedio J., & Saah A.J. (1990). Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: A prospective evaluation. Annals of Internal Medicine, 113, 740–746.
38. Holodnick C.L., & Barkauskas V. (2000). Reducing percutaneous injuries in the OR by educational methods. AORN Journal, 72, 461–472, 475.
39. Holtgrave D.R., & Pinkerton S.D. (1997). Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 16, 54–62.
40. International Health Care Worker Safety Center (IHCWSC). (2000). Exposure prevention information network (EPINet). Retrieved October 28, 2003, from www.healthsystem.virginia.edu/inter-net/epinet/epinet4.cfm
41. International Health Care Worker Safety Center (IHCWSC). (2003). Uniform needlestick and sharp object injury report 58 hospitals, 2001. University of Virginia. Retrieved September 12, 2003, from www.healthsystem.virginia.edu/internet/epinet/soi01.cfm
42. Jackson M.A., Williams K., Olson-Burgess C., Kinney J., Olson L.C., & Burry V.F. (1994). Needlestick injuries in a pediatric hospital. Pediatric Infectious Disease Journal, 13, 318–320.
43. Jagger J., Hunt E.H., & Pearson R.D. (1990). Estimated cost of needlestick injuries for six major needled devices. Infection Control and Hospital Epidemiology, 11, 584–588.
44. John Doe v. Yale University, 748 A.2d 834 (Conn. 2000).
45. Lanphear B.P., Linnemann C.C. Jr., Cannon C.G., DeRonde M.M., Pendy L., & Kerley L.M. (1994). Hepatitis C virus infection in healthcare workers: Risk of exposure and infection. Infection Control and Hospital Epidemiology, 15, 745–750.
46. Linnemann C.C. Jr., Cannon C., DeRonde M., & Lanphear B. (1991). Effect of educational programs, rigid sharps containers, and universal precautions on reported needlestick injuries in healthcare workers. Infection Control and Hospital Epidemiology, 12, 214–219.
47. Llewellyn J., Giese R., Nosek L.J., Lager J.D., Turco S.J., Goodell J., Coleman J., McQuone M.J., Collier P.A., & Minard D.A. (1994). A multicenter study of costs and nursing impact of cartridge-needle units. Nursing Economics, 12, 208–214.
48. Longbottom H.M., Cox K., & Sokas R.K. (1993). Body fluid exposure in an urban tertiary care medical center. American Journal of Industrial Medicine, 23, 703–710.
49. Lulloff S.J., Vergeront J.M., Druckenmiller J., & Hoxie N.J. (1996). The incidence of needlestick and sharps injuries and use of safer devices in Wisconsin hospitals. Wisconsin Medical Journal, 95, 379–381.
50. Mangione C.M., Gerberding J.L., & Cummings S.R. (1991). Occupational exposure to HIV: Frequency and rates of underreporting of percutaneous and mucocutaneous exposures by medical housestaff. The American Journal of Medicine, 90, 85–90.
51. McCormick R.D., Meisch M.G., Ircink E.G., & Maki D.G. (1991). Epidemiology of hospital sharps injuries: A 14-year prospective study in the pre-AIDS and AIDS eras. The American Journal of Medicine, 91 (Suppl. 3B), 301S–307S.
52. Meisenhelder J.B. (1998). Accidental occupational exposure of intravenous nurses to human immunodeficiency virus: Anticipating the consequences. Journal of Intravenous Nursing, 21, 215–220.
53. Mendelson M.H., Short L.J., Schechter C.B., Meyers B.R., Rodriguez M., Cohen S., Lozada J., DeCambre M., & Hirschman S.Z. (1998). Study of a needleless intermittent intravenous-access system for peripheral infusions: Analysis of staff, patient, and institutional outcomes. Infection Control and Hospital Epidemiology, 19, 401–406.
54. Moore R.D., & Chaisson R.E. (1997). Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 14, 223–231.
55. Moore R.D., Hidalgo J., Bareta J.C., & Chaisson R.E. (1994). Zidovudine therapy and health resource utilization in AIDS. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 7, 349–354.
56. Nelson T.J. (1999). Towards an objective definition of morality. Retrieved November 5, 2003, from www.tjnelson.com/morality.htm
57. Occupational Safety and Health Administration (OSHA). (1992). OSHA instruction CPL 2-2.44C: Enforcement procedures for the occupational exposure to bloodborne pathogens. Washington, DC: OSHA Directorate of Compliance Programs.
58. Occupational Safety and Health Administration (OSHA). (1998). Occupational exposure to bloodborne pathogens: Request for information. 63 Federal Register 48,250-48,252.
59. Occupational Safety and Health Administration (OSHA). (1999). OSHA Instruction CPL 2-2.44D: Enforcement procedures for the occupational exposure to bloodborne pathogens. Washington, DC: OSHA Directorate of Compliance Programs.
60. Occupational Safety and Health Administration (OSHA). (2001a). Occupational exposure to bloodborne pathogens: Needlesticks and other sharps injuries; Final rule. 29 CFR Part 1910. Washington, DC: U.S. Department of Labor.
61. Occupational Safety and Health Administration (OSHA). (2001b). OSHA instruction CPL 202.69: Enforcement procedures for the occupational exposure to bloodborne pathogens. Washington, DC: OSHA Directorate of Compliance Programs.
62. Orenstein R., Reynolds L., Karabaic M., Lamb A., Markowitz S.M., & Wong E.S. (1995). Do protective devices prevent needlestick injuries among health care workers? American Journal of Infection Control, 23, 344–351.
63. Patterson J.M., Novak C.B., Mackinnon S.E., & Ellis R.A. (2003). Needlestick injuries among medical students. American Journal of Infection Control, 31, 226–230.
64. Pinkerton S.D., Holtgrave D.R., & Pinkerton H.J. (1997). Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Archives of Internal Medicine, 157, 1972–1980.
65. Ramsey S.D., & Nettleman M.D. (1992). Cost-effectiveness of prophylactic AZT following needlestick injury in health care workers. Medical Decision Making, 12, 142–148.
66. Reed Tool Co. v. Copelin, 689S.W.2d 404 (Texas 1985).
67. Riley v. Becton Dickinson Vascular Access, Inc., 913 F. Supp. 879 (E.D. Pa. 1995).
68. Ritota P.C., Quirke T.E., & Byer A. (1996). Influence of HIV-infection risk on resident physicians. Academic Medicine, 71, 684–686.
69. Rodriguez v. Naylor Industries, Inc., 763 S.W.2d 411 (Texas 1989).
70. Rowe P.M., & Giuffre M. (1991). Evaluating needlestick injuries in nursing personnel. Development of a questionnaire. AAOHN Journal, 39(11), 503–507.
71. Salomon J.A., Weinstein M.C., Hammitt J.K., & Goldie S.J. (2003). Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. Journal of the American Medical Association, 290, 228–237.
72. Schackman B.R., Goldie S.J., Weinstein M.C., Losina E., Zhang H., & Freedberg K.A. (2001). Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. American Journal of Public Health, 91, 1456–1463.
73. Sellick J.A. Jr., Hazamy P.A., & Mylotte J.M. (1991). Influence of an educational program and mechanical opening needle disposal boxes on occupational needlestick injuries. Infection Control and Hospital Epidemiology, 12, 725–731.
74. Sinclair R.C., Maxfield A., Marks E.L., Thompson D.R., & Gershon R.R. (2002). Prevalence of safer needle devices and factors associated with their adoption: Results of a national hospital survey. Public Health Reports, 117, 340–349.
75. Sistrom M.G., Coyner B.J., Gwaltney J.M. Jr., & Farr B.M. (1998). Frequency of percutaneous injuries requiring postexposure prophylaxis for occupational exposure to human immunodeficiency virus. Infection Control and Hospital Epidemiology, 19, 504–506.
76. Skolnick R., LaRocca J., Barba D., & Paicius L. (1993). Evaluation and implementation of a needleless intravenous system: Making needlesticks a needless problem. American Journal of Infection Control. 21(1), 39–41.
77. Stotka J.L., Wong E.S., Williams D.S., Stuart C.G., & Markowitz S.M. (1991). An analysis of blood and body fluid exposures sustained by house officers, medical students, and nursing personnel on acute-care general medical wards: A prospective study. Infection Control and Hospital Epidemiology, 12, 583–590.
78. Tait A.R., & Tuttle D.B. (1994). Prevention of occupational transmission of human immunodeficiency virus and hepatitis B virus among anesthesiologists: A survey of anesthesiology practice. Anesthia & Analgesia, 79, 623–628.
79. Tandberg D., Stewart K.K., & Doezema D. (1991). Under-reporting of contaminated needlestick injuries in emergency health care workers. Annals of Emergency Medicine, 20, 66–70.
80. Tereskerz P.M. (1997). Legal implications of needlestick injuries. Journal of Intravenous Nursing, 20 (Suppl. 6), S25–S32.
81. Tokars J.I., Marcus R., Culver D.H., Schable C.A., McKibben P.S., Bandea C.I., & Bell D.M. (1993). Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood: The CDC Cooperative Needlestick Surveillance Group. Annals of Internal Medicine, 118, 913–919.
82. Twitched K.T. (2003). Bloodborne pathogens: What you need to know—Part I. AAOHN Journal, 51(1), 38–45.
83. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). (2001). Updated U.S. public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Morbidity and Mortality Weeekly Report, 50, 1–52.
84. Vergilio J.A., Roberts R.B., & Davis J.M. (1993). The risk of exposure of third-year surgical clerks to human immunodeficiency virus in the operating room. Archives of Surgery, 128(1), 36–38.
85. Wears R.L., Vukich D.J., Winton C.N., Fluskey L.L., MacMath T.R., & Li S. (1991). An analysis of emergency physicians' cumulative career risk of HIV infection. Annals of Emergency Medicine, 20, 749–753.
86. Weatherly K.S., Young S., & Andresky J. (1991). Needle stick injury in pediatric hospitals. Pediatric Nursing, 17, 95–99.
87. Wilner N.A. (1997). Using a value chain approach for effective decision making. Journal of Healthcare Resource Management, 15(7), 20–23.
88. Wong J.B. (1998). Interferon treatment for chronic hepatitis B or C infection: Costs and effectiveness. Acta Gastroenterologica Belgica, 61, 238–242.
89. Wong J.B. (1999). Cost-effectiveness of treatments for chronic hepatitis C. American Journal of Medicine, 107 (Suppl. 6B), 74S–78S.
90. Wong J.B., & Koff R.S. (2000). Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C: A cost-effectiveness analysis. Annals of Internal Medicine, 133, 665–675.
91. Wong J.B., Koff R.S., Tine F., & Pauker S.G. (1995). Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B. Annals of Internal Medicine, 122, 664–675.
92. Yeh J.M., Botteman M., Pashos C.L., Postma M.J., & Staginnus U. (2002). Economics of transfusion. Infusion Therapy and Transfusion Medicine, 29, 218–225.